These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17440771)

  • 21. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.
    Kao WY; Su CW; Chau GY; Lui WY; Wu CW; Wu JC
    World J Surg; 2011 Apr; 35(4):858-67. PubMed ID: 21207029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
    Toro A; Ardiri A; Mannino M; Arcerito MC; Mannino G; Palermo F; Bertino G; Di Carlo I
    BMC Surg; 2014 Jul; 14():40. PubMed ID: 24993566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.
    Yang JD; Kim WR; Coelho R; Mettler TA; Benson JT; Sanderson SO; Therneau TM; Kim B; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):64-70. PubMed ID: 20831903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
    Perz JF; Armstrong GL; Farrington LA; Hutin YJ; Bell BP
    J Hepatol; 2006 Oct; 45(4):529-38. PubMed ID: 16879891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.
    Benvegnù L; Gios M; Boccato S; Alberti A
    Gut; 2004 May; 53(5):744-9. PubMed ID: 15082595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2013 Dec; 19(47):8861-6. PubMed ID: 24379608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections.
    Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Miyakawa Y; Kumada H
    J Med Virol; 2006 Apr; 78(4):459-65. PubMed ID: 16482557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA.
    Tong MJ; Chavalitdhamrong D; Lu DS; Raman SS; Gomes A; Duffy JP; Hong JC; Busuttil RW
    J Clin Gastroenterol; 2010 Mar; 44(3):e63-70. PubMed ID: 19745756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.
    Conci S; Cipriani F; Donadon M; Marchitelli I; Ardito F; Famularo S; Perri P; Iaria M; Ansaloni L; Zanello M; La Barba G; Patauner S; Pinotti E; Molfino S; Germani P; Romano M; Sciannamea I; Ferrari C; Manzoni A; Troci A; Fumagalli L; Delvecchio A; Floridi A; Memeo R; Chiarelli M; Crespi M; Zimmitti G; Griseri G; Antonucci A; Zanus G; Tarchi P; Baiocchi GL; Zago M; Frena A; Ercolani G; Jovine E; Maestri M; Valle RD; Grazi GL; Romano F; Giuliante F; Torzilli G; Aldrighetti L; Ruzzenente A;
    Eur J Surg Oncol; 2022 Jan; 48(1):103-112. PubMed ID: 34325939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology of hepatocellular carcinoma in a rural area. Role of hepatotrophic viruses on survival].
    Rodríguez-Vidigal FF; Baz MJ; Romero J; del Puerto M
    An Med Interna; 2005 Apr; 22(4):162-6. PubMed ID: 16004511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.
    Huo TI; Wu JC; Hsia CY; Chau GY; Lui WY; Huang YH; Lee PC; Chang FY; Lee SD
    World J Surg; 2004 Aug; 28(8):787-91. PubMed ID: 15457359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia.
    Jasirwan COM; Hasan I; Sulaiman AS; Lesmana CRA; Kurniawan J; Kalista KF; Nababan SH; Gani RA
    Curr Probl Cancer; 2020 Feb; 44(1):100480. PubMed ID: 31130257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.